Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aging brain and dementias: changes in central opioids.

G Nappi1, E Sinforiani, E Martignoni

  • 1Department of Neurology, C. Mondino Foundation, University of Pavia, Italy.

European Neurology
|January 1, 1988
PubMed
Summary

CSF levels of beta-lipotropin, beta-endorphin, and ACTH were analyzed in dementia patients. Reduced ACTH is common in all dementia types, while beta-lipotropin and beta-endorphin reductions indicate central nervous system degeneration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen.

Anticancer research·2001
Same author

Serum allopregnanolone in women with postpartum "blues".

Obstetrics and gynecology·2001
Same author

The use of a starting dose of recombinant follicle stimulating hormone for controlled ovarian hyperstimulation: a randomized pilot study.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000
Same author

Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000
Same author

Ovarian follicular fluid contains immunoreactive estriol: lack of correlation with estradiol concentrations.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000
Same author

Dose-response efficacy of a new estradiol transdermal matrix patch for 7-day application: a randomized, double-blind, placebo-controlled study. Italian Menopause Research Group.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000

Area of Science:

  • Neuroscience
  • Biochemistry
  • Gerontology

Background:

  • Pro-opiomelanocortin (POMC) gene encodes key neuropeptides: beta-lipotropin (beta-LPH), beta-endorphin (beta-EP), and ACTH.
  • Dementia, encompassing Alzheimer-type dementia (ATD) and multi-infarct dementia (MID), involves complex neurobiological changes.
  • Alterations in neuropeptide levels may serve as biomarkers for different dementia subtypes.

Purpose of the Study:

  • To investigate cerebrospinal fluid (CSF) levels of beta-LPH, beta-EP, and ACTH in patients with degenerative (ATD) and vascular (MID) dementia.
  • To determine if specific neuropeptide level changes correlate with dementia type or progression.
  • To explore the potential of these neuropeptides as indicators of central nervous system (CNS) degenerative processes.

Main Methods:

Related Experiment Videos

  • CSF samples were collected from patients diagnosed with ATD and MID, alongside sex- and age-matched healthy controls.
  • Quantification of beta-LPH, beta-EP, and ACTH concentrations in CSF using established biochemical assays.
  • Statistical analysis to compare neuropeptide levels across patient groups and controls.

Main Results:

  • Significantly reduced ACTH levels were observed in both ATD and MID patient groups compared to controls.
  • Beta-EP and beta-LPH levels were significantly decreased exclusively in ATD patients.
  • These findings suggest distinct neuropeptide profiles associated with different dementia pathologies.

Conclusions:

  • Low CSF ACTH levels are characteristic of both degenerative and vascular dementia processes.
  • Reduced CSF beta-EP and beta-LPH levels may specifically indicate a degenerative component within the CNS, as seen in ATD.
  • Neuropeptide analysis in CSF holds potential for differentiating dementia subtypes and understanding underlying neuropathology.